Batch of 12,000 blood plasma found contaminated with HIV in China

Image
IANS Beijing
Last Updated : Feb 07 2019 | 12:45 PM IST

A batch of over 12,000 human blood plasma has been found contaminated with HIV in China and the government has launched a probe into the latest medical scandal in the country.

A batch of Intravenous immunoglobulin, a product made of human blood plasma to treat a weak immune system, was tested positive for HIV. The drug was manufactured by Shanghai-based company Shanghai Xinxing Pharmaceutical.

China's National Health Commission (NHC), which launched an investigation into the matter, said experts believe the risk of HIV infection in patients using the drug was very low.

According to Beijing News, a news portal in Chinese, a total of 12,226 50ml bottles of the product were issued and approved by the Shanghai food and drug testing institute under the Shanghai Food and Drug Administration.

The batches of the product expire in June 2021.

The NHC ordered the suspension the use of the batches of products by the hospitals.

"According to international relevant literature reports, combined with the characteristics of the production process of the drug inactivated virus and the PH value of the product, experts believe that the risk of HIV infection in patients using the drug is very low," the NHC said in a statement.

This is the third big health scandal hitting China since July 2018 when hundreds of children were administered expired polio vaccines.

This week some 29 children were given wrong vaccines.

--IANS

gsh/soni/

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 07 2019 | 12:38 PM IST

Next Story